Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 9 | 2022 | 883 | 2.050 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2023 | 101 | 1.550 |
Why?
|
| Death, Sudden | 2 | 2016 | 59 | 1.040 |
Why?
|
| Epilepsies, Partial | 4 | 2020 | 111 | 1.020 |
Why?
|
| Epilepsy, Generalized | 2 | 2020 | 71 | 0.790 |
Why?
|
| Spasms, Infantile | 1 | 2022 | 165 | 0.760 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2019 | 7 | 0.720 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2018 | 94 | 0.620 |
Why?
|
| Sudden Infant Death | 1 | 2016 | 33 | 0.550 |
Why?
|
| Penetrance | 1 | 2014 | 126 | 0.490 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 253 | 0.460 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 5539 | 0.450 |
Why?
|
| Cognition Disorders | 1 | 2018 | 786 | 0.440 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 473 | 0.410 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 2488 | 0.370 |
Why?
|
| Brain | 1 | 2019 | 4113 | 0.270 |
Why?
|
| Heterozygote | 3 | 2019 | 1020 | 0.270 |
Why?
|
| Seizures | 2 | 2020 | 989 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 641 | 0.220 |
Why?
|
| Glycosylation | 1 | 2022 | 213 | 0.210 |
Why?
|
| Temporal Lobe | 1 | 2023 | 192 | 0.200 |
Why?
|
| Chromosome Deletion | 1 | 2006 | 1005 | 0.200 |
Why?
|
| Implantable Neurostimulators | 1 | 2020 | 18 | 0.190 |
Why?
|
| Abnormalities, Multiple | 2 | 2007 | 998 | 0.190 |
Why?
|
| Brain Stem | 1 | 2020 | 175 | 0.180 |
Why?
|
| Electric Stimulation Therapy | 1 | 2020 | 116 | 0.170 |
Why?
|
| Dynamins | 1 | 2019 | 74 | 0.170 |
Why?
|
| Electrodes, Implanted | 1 | 2019 | 183 | 0.170 |
Why?
|
| Hippocampus | 2 | 2023 | 915 | 0.160 |
Why?
|
| Intellectual Disability | 1 | 2006 | 1032 | 0.160 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2020 | 181 | 0.150 |
Why?
|
| ERG1 Potassium Channel | 1 | 2016 | 3 | 0.140 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2016 | 7 | 0.140 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2016 | 12 | 0.140 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2016 | 20 | 0.140 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2016 | 13 | 0.140 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2016 | 36 | 0.140 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2016 | 39 | 0.140 |
Why?
|
| Brain Diseases | 1 | 2019 | 403 | 0.130 |
Why?
|
| Humans | 16 | 2023 | 261506 | 0.130 |
Why?
|
| Potassium Channels | 1 | 2016 | 162 | 0.130 |
Why?
|
| Infant | 3 | 2018 | 13310 | 0.130 |
Why?
|
| Mutation | 1 | 2014 | 15179 | 0.120 |
Why?
|
| Chloride Channels | 1 | 2013 | 60 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 2013 | 145 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 14889 | 0.090 |
Why?
|
| Adult | 8 | 2020 | 77950 | 0.090 |
Why?
|
| Ion Channels | 1 | 2011 | 212 | 0.090 |
Why?
|
| Deep Brain Stimulation | 1 | 2015 | 348 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 332 | 0.090 |
Why?
|
| Male | 9 | 2020 | 123000 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2011 | 272 | 0.080 |
Why?
|
| Adolescent | 5 | 2020 | 31252 | 0.080 |
Why?
|
| Ethics, Medical | 1 | 2011 | 442 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2018 | 16273 | 0.070 |
Why?
|
| Young Adult | 4 | 2020 | 21445 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5687 | 0.070 |
Why?
|
| Stroke | 1 | 2015 | 1144 | 0.070 |
Why?
|
| Quality of Life | 1 | 2020 | 4532 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 233 | 0.070 |
Why?
|
| Mutation, Missense | 3 | 2019 | 1152 | 0.060 |
Why?
|
| Female | 9 | 2020 | 141928 | 0.060 |
Why?
|
| Electroencephalography | 2 | 2007 | 898 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2013 | 2086 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2011 | 806 | 0.060 |
Why?
|
| Video Recording | 1 | 2006 | 267 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2012 | 1589 | 0.060 |
Why?
|
| DNA | 1 | 2012 | 2693 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 7222 | 0.060 |
Why?
|
| Syndrome | 1 | 2006 | 1351 | 0.050 |
Why?
|
| Child | 2 | 2018 | 29154 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 7702 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 1471 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2007 | 1442 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 4053 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2007 | 1555 | 0.050 |
Why?
|
| Genomics | 1 | 2011 | 2738 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2006 | 795 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 121 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 4549 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 5159 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 49 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2020 | 145 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 416 | 0.040 |
Why?
|
| Suicide | 1 | 2020 | 180 | 0.040 |
Why?
|
| Risk Factors | 1 | 2015 | 17523 | 0.040 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 232 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2020 | 295 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 336 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2020 | 557 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2018 | 37905 | 0.030 |
Why?
|
| Animals | 3 | 2015 | 59536 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 2437 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 12873 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 1282 | 0.030 |
Why?
|
| Consent Forms | 1 | 2011 | 25 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 2594 | 0.030 |
Why?
|
| Genetic Privacy | 1 | 2011 | 40 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 119 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 457 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 409 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2012 | 299 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 2588 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2011 | 319 | 0.020 |
Why?
|
| Informed Consent | 1 | 2011 | 419 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2020 | 32848 | 0.020 |
Why?
|
| Aged | 3 | 2020 | 70117 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 1529 | 0.020 |
Why?
|
| Craniofacial Abnormalities | 1 | 2007 | 239 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 86204 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2007 | 436 | 0.020 |
Why?
|
| Genome, Human | 1 | 2011 | 1869 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 6150 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 12926 | 0.010 |
Why?
|
| Neurons | 1 | 2011 | 2287 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 9244 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 34495 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 6869 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 5710 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 6942 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 7548 | 0.010 |
Why?
|
| Phenotype | 1 | 2007 | 6295 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 29902 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 15193 | 0.000 |
Why?
|